Review Article

Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview

Table 8

Effect of soy protein or isoflavone in soy on apoA-I concentrations.

First author, yearFood component/productStudy design and durationParticipantsIntakeEffect

Bakhit et al. (1994) [115]Soybean protein with or without soybean fiberRCT crossover
4 weeks
21 hypercholesterolemic men25 g/day(i) No differences in fasting plasma apoA-I concentrations

Kurowska et al. (1997) [116]Soy protein versus milk proteinRCT crossover
4 weeks
34 hypercholesterolemic subjects2% of daily intake(i) No differences in fasting plasma apoA-I concentrations

Nilausen and Meinertz (1998) [117]Soy protein versus casein (similar macronutrient composition)RCT crossover
1 month
9 healthy men154 g/day(i) 10.7% in fasting plasma apoA-I

Jenkins et al. (2000) [118]Soy incorporated into breakfast cereals versus no soyRCT crossover
3 weeks
25 hyperlipidemic subjects36 g/day(i) No differences in fasting serum apoA-I concentrations

Chen et al. (2006) [119]Soy protein versus milk proteinRCT parallel
3 months
26 patients undergoing hypercholesterolaemic hemodialysis30 g/day(i) No differences in fasting serum apoA-I concentrations

McVeigh et al. (2006) [120]Soy protein varying in isoflavone contentRCT crossover
57 days
35 healthy young men1.64–61.7 mg isoflavone/day(i) No differences in fasting serum apoA-I concentrations

Pipe et al. (2009) [121]Soy protein isolate versus milk protein isolateRCT crossover
57 days
29 patients with diabetes mellitus type 280 g/day(i) No differences in fasting serum apoA-I concentrations

Campbell et al. (2010) [122]Soy protein products versus casein productsRCT parallel
1 year
62 moderately hypercholesterolemic postmenopausal women25 g/day(i) 8.5% in fasting serum apoA-I

Tabibi et al. (2010) [123]Soy protein versus no soy proteinRCT parallel
8 weeks
40 peritoneal dialysis patients28 g/day(i) No differences in fasting serum apoA-I concentrations

Jenkins et al. (2002) [124]High versus low isoflavone soy proteinRCT crossover
1 months
41 hyperlipidemic subjectsSoy: 50–52 g/day; isoflavones: 73 versus 10 mg/day(i) No differences in fasting serum apoA-I concentrations

Cicero et al. (2002) [125]Soy proteins supplemented with isolated β-sitosterol versus no soy proteinRCT parallel
40 days
20 moderately hypercholesterolemic subjects10 g/day(i) No differences in fasting plasma apoA-I concentrations

Matthan et al. (2007) [126]Different sources of soy protein versus animal proteinRCT crossover
6 weeks
28 hypercholesterolemic subjects6.8–7.5 energy%/day(i) 2.0% in fasting plasma apoA-I concentrations comparing soy-milk with soybean and soy flour
(ii) No differences in fasting plasma apoA-I concentrations comparing soy with animal protein

Bakhtiary et al. (2012) [127]Soy protein versus soy nuts versus no soyRCT parallel
3 months
75 women with the metabolic syndrome35 g/day(i) 18.8% in fasting serum apoA-I concentrations comparing soy protein with
(ii) 25.0% in fasting serum apoA-I concentrations comparing soy nuts with

Wangen et al. (2001) [128]No versus low versus high soy isoflavoneRCT crossover
3 months
18 mildly hypercholesterolemic women7.1, 65, 132 mg/day(i) No differences in fasting plasma apoA-I concentrations

Santo et al. (2010) [129]Milk protein versus isoflavone-poor soy versus isoflavone-rich soyRCT crossover
28 days
30 healthy young men25 g protein/day(i) No differences in fasting and postprandial plasma apoA-I concentrations

Percentages calculated from the mean values.